Drug Androcur and generic : what are the risks ?

MIL OSI Translation. Region: France and French Territories –

Source: Republic of France in French

Credits : © Gstudio Group – Fotolia.com

In the framework of a study pharmaco-epidemiological carried out by the health Insurance on 250 000 women exposed to cyproterone acetate (a drug Androcur and generic), the results of this study suggest that the risk of tumour (meningioma) is multiplied by 7 for women treated by large doses over a long period (over 6 months) and by 20 after 5 years of treatment.

Given these new data indicate that the risk increases as a function of the duration of use and dosage of this drug is used, in particular in case of a problem of excess body hair, the national security Agency of medicines and health products (MSNA) should issue soon new recommendations.

In the meantime patients with questions about their treatment are invited to consult their doctor or their pharmacist, but in no case must decide whether to stop without the advice of their doctor.

Namely :

The meningioma is a tumor, most often benign, that develops from the membranes that envelop the brain and spinal cord (the meninges).

EDITOR’S NOTE: This article is a translation. Apologies should the grammar and/or sentence structure is not be perfect.